中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2025-06-302025-03-312024-12-312024-09-302024-06-30
营业总收入(万元)1576119.36720561.112798460.532018930.381360073.41
营业收入(万元)1576119.36720561.112798460.532018930.381360073.41
营业总成本(万元)1089980.16512854.182101154.141508997.92975600.04
营业成本(万元)211496.22106866.25384817.74283318.27187330.37
净利润(万元)447655.04187650.22633417.49460807.66343097.53
归属于母公司的净利润(万元)445010.64187405.55633652.70461957.59343174.81
营业利润(万元)515889.27208598.09749063.20534529.05398477.61
利润总额(万元)505093.42207560.37716969.00508674.02375160.01
少数股东损益(万元)456.43238.6446.76-324.57-361.57
基本每股收益(元)0.70(元)0.30(元)1.00(元)0.73(元)0.54(元)
稀释每股收益(元)0.70(元)0.30(元)1.00(元)0.73(元)0.54(元)
非经常性损益(万元)--1076.8915856.05----
扣除非经常性损益后净利润(万元)427284.85186328.66617796.65461631.48349005.15
总资产(万元)6289351.715129278.175013564.534833809.944818136.00
总负债(万元)386371.91374301.26404539.46400658.07499422.39
归属于母公司股东权益合计(万元)5846483.124698705.954551986.194376790.884262224.28
股东权益合计(万元)5902979.804754976.914609025.074433151.874318713.62
实收资本(股本)(万元)663719.99637900.23637900.23637900.23637900.23
资本公积(万元)1287149.67285387.48318807.26322235.23316704.24
未分配利润(万元)3704150.523573958.453386552.903214857.793096075.01
经营活动产生的现金流量净额(万元)430045.3355517.41742275.30458544.60303275.48
经营活动现金流入小计(万元)1612379.40630193.652846888.172054679.711383831.96
经营活动现金流出小计(万元)1182334.08574676.242104612.871596135.111080556.47
投资活动产生的现金流量净额(万元)-108473.29-53167.76-191198.57-187344.65-152359.24
投资活动现金流入小计(万元)18283.2017035.4367989.2225122.104108.13
投资活动现金流出小计(万元)126756.4970203.19259187.79212466.75156467.37
筹资活动产生的现金流量净额(万元)803949.50-66105.92-155059.00-150652.41-13856.75
筹资活动现金流入小计(万元)1035193.79--79990.9479990.9479990.94
筹资活动现金流出小计(万元)231244.2966105.92235049.94230643.3493847.69
期末现金及现金等价物余额(万元)3554260.512363116.362423910.212145578.022163628.07
最后修改日期2025-08-212025-04-252025-03-312024-10-242024-08-21
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。